IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

RP Management, LLC

Q2 2019 Holdings

Filed 2019-08-07 | 4 holdings | $10.0M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Cytokinetics Inc(CYTK)COM NEW23282W605$9.9M875,65698.5%
Biohaven Pharmactl Hldg Co L(BHVN)COMG11196105$92.4K2,111,1110.9%
Immunomedics Inc(IMMU)COM452907108$60.7K4,373,1780.6%
Sunesis Pharmaceuticals IncCOM PAR867328700$95129,5170.0%